Elevated serum FGF21 is an independent predictor for adverse events in hemodialysis patients from two large centers: a prospective cohort study

Elevated serum FGF21 is an independent predictor for adverse events in hemodialysis patients from two large centers: a prospective cohort study

Introduction We explored the relationship and the predictive value of serum fibroblast growth factor 21 (FGF21) with all-cause mortality, major adverse cardiovascular events (MACEs) and pneumonia in hemodialysis (HD) patients.Methods A total of 388 Chinese HD patients from two HD centers were finall...

Full description

Bibliographic Details
Main Authors: Min Li, Li-qiong Jiang, Meng-yu Zhang, Shu-su Liu, Rejean-Ruiel Regis Sawh, Jing Zheng, Yu Yan, Shi-mei Hou, Ke-qi Lu, Obadele Thorne, Bi-cheng Liu, Qing Qian, Yan-feng Wu, Min Yang, Bin Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
All-cause mortality
fibroblast growth factor 21
hemodialysis
major adverse cardiovascular events
pneumonia
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2256414

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2256414

Similar Items